Yi Zheng

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Molecular Dynamics Simulations

Embryonic Stem Cells

Dna Methylation

Top Venues

Nature communications

Cancer research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander William Thorman, James Reigle, Somchai Chutipongtanate, Juechen Yang, Behrouz Shamsaei, Marcin Pilarczyk, Mehdi Fazel-Najafabadi, Rafal Adamczak, Michal Kouril, Surbhi Bhatnagar, Sarah A Hummel, Wen Niu, Ardythe L Morrow, Maria F Czyzyk-Krzeska, Robert E McCullumsmith, William L Seibel, Nicolas Nassar, Yi Zheng, David A Hildeman, Mario Medvedovic, Andrew B Herr, Jaroslaw Meller
Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking. Science advances 10 (35) (2024)
Yi Zheng
Conditioning for alloengraftment in FA. Blood 143 (21) (2024)
Yuan Lin, Theresa A Ramelot, Simge Senyuz, Attila Gürsoy, Hyunbum Jang, Ruth Nussinov, Ozlem Keskin, Yi Zheng
Tumor-derived RHOA mutants interact with effectors in the GDP-bound state. Nature communications 15 (1) (2024)
Shailaja Hegde, Huzoor Akbar, Ashley Wellendorf, Shawnagay Nestheide, James F Johnson, Xueheng Zhao, Kenneth D R Setchell, Yi Zheng, Jose A Cancelas
Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold stored platelets. Blood (2024)
Shailaja Hegde, Huzoor Akbar, Ashley Wellendorf, Shawnagay Nestheide, James F Johnson, Xueheng Zhao, Kenneth D R Setchell, Yi Zheng, Jose A Cancelas
Inhibition of RHOA activity preserves the survival and hemostasis function of long-term cold stored platelets. Blood (2024)
Yuan Lin, Theresa A Ramelot, Simge Senyuz, Attila Gürsoy, Hyunbum Jang, Ruth Nussinov, Ozlem Keskin, Yi Zheng
Tumor-derived RHOA mutants interact with effectors in the GDP-bound state. Nature communications 15 (1) (2024)
Yuan Lin, Theresa A Ramelot, Simge Senyuz, Attila Gürsoy, Hyunbum Jang, Ruth Nussinov, Ozlem Keskin, Yi Zheng
Tumor-derived RHOA mutants interact with effectors in the GDP-bound state. Nature communications 15 (1) (2024)
Chen Wang, Zhaowei Tu, Xiongwei Cai, Weinan Wang, Ashley Kuenzi Davis, Kalpana J Nattamai, Aditi Paranjpe, Phillip J Dexheimer, Jianqiang Wu, L Frank Huang, Hartmut Geiger, Gang Huang, Yi Zheng
A Critical Role of RUNX1 in Governing Megakaryocyte-Primed Hematopoietic Stem Cell Differentiation. Blood advances (2023)
Cuiqing Fan, Mark Wunderlich, Xiongwei Cai, Zijun Yan, Feng Zhang, Ashley Kuenzi Davis, Lingli Xu, Fukun Guo, Qing Richard Lu, Mohammad Azam, Weidong Tian, Yi Zheng
Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor. Leukemia (2023)
Kee-Beom Kim, Dong-Wook Kim, Youngchul Kim, Jun Tang, Nicole Kirk, Yongyu Gan, Bongjun Kim, Bingliang Fang, Jae-Il Park, Yi Zheng, Kwon-Sik Park
WNT5A-RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer. Cancer research 82 (22) (2022)
Laurel Romano, Katie M Giger, Julien Papoin, David E Muench, Diamantis Konstantinidis, André Olsson, Katrina Schlum, Kashish Chetal, Joel Anne Chasis, Narla Mohandas, Betsy J Barnes, Yi Zheng, H Leighton Grimes, Nathan Salomonis, Lionel Blanc, Theodosia A Kalfa
Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis. Blood 140 (14) (2022)
Zheng Zhang, Ming Liu, Yi Zheng
Role of Rho GTPases in stem cell regulation. Biochemical Society transactions (2021)